AU2002240489C1 - Enzymes having alpha amylase activity and methods of use thereof - Google Patents
Enzymes having alpha amylase activity and methods of use thereof Download PDFInfo
- Publication number
- AU2002240489C1 AU2002240489C1 AU2002240489A AU2002240489A AU2002240489C1 AU 2002240489 C1 AU2002240489 C1 AU 2002240489C1 AU 2002240489 A AU2002240489 A AU 2002240489A AU 2002240489 A AU2002240489 A AU 2002240489A AU 2002240489 C1 AU2002240489 C1 AU 2002240489C1
- Authority
- AU
- Australia
- Prior art keywords
- polypeptide
- sequence
- set forth
- nucleic acid
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 238000000034 method Methods 0.000 title claims abstract description 345
- 230000000694 effects Effects 0.000 title claims abstract description 109
- 108090000637 alpha-Amylases Proteins 0.000 title claims abstract description 51
- 102000004139 alpha-Amylases Human genes 0.000 title claims abstract description 49
- 102000004190 Enzymes Human genes 0.000 title claims description 105
- 108090000790 Enzymes Proteins 0.000 title claims description 105
- 229940088598 enzyme Drugs 0.000 title claims description 88
- 229940024171 alpha-amylase Drugs 0.000 title claims description 38
- 239000002157 polynucleotide Substances 0.000 claims abstract description 133
- 108091033319 polynucleotide Proteins 0.000 claims abstract description 132
- 102000040430 polynucleotide Human genes 0.000 claims abstract description 132
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 457
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 451
- 229920001184 polypeptide Polymers 0.000 claims description 445
- 150000007523 nucleic acids Chemical class 0.000 claims description 353
- 102000039446 nucleic acids Human genes 0.000 claims description 227
- 108020004707 nucleic acids Proteins 0.000 claims description 227
- 229920002472 Starch Polymers 0.000 claims description 161
- 239000008107 starch Substances 0.000 claims description 160
- 235000019698 starch Nutrition 0.000 claims description 153
- 108090000623 proteins and genes Proteins 0.000 claims description 128
- 239000012634 fragment Substances 0.000 claims description 127
- 108010065511 Amylases Proteins 0.000 claims description 101
- 210000004027 cell Anatomy 0.000 claims description 101
- 102000013142 Amylases Human genes 0.000 claims description 100
- 235000019418 amylase Nutrition 0.000 claims description 95
- 125000003729 nucleotide group Chemical group 0.000 claims description 82
- 239000002773 nucleotide Substances 0.000 claims description 81
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 77
- 239000000523 sample Substances 0.000 claims description 73
- 239000013598 vector Substances 0.000 claims description 71
- 239000004382 Amylase Substances 0.000 claims description 67
- 150000001413 amino acids Chemical class 0.000 claims description 66
- 238000006243 chemical reaction Methods 0.000 claims description 64
- 102000004169 proteins and genes Human genes 0.000 claims description 63
- 108020004414 DNA Proteins 0.000 claims description 61
- 239000000758 substrate Substances 0.000 claims description 60
- 238000002703 mutagenesis Methods 0.000 claims description 59
- 231100000350 mutagenesis Toxicity 0.000 claims description 59
- 239000000203 mixture Substances 0.000 claims description 58
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 50
- 150000003384 small molecules Chemical class 0.000 claims description 42
- 230000004048 modification Effects 0.000 claims description 39
- 238000012986 modification Methods 0.000 claims description 38
- 230000000295 complement effect Effects 0.000 claims description 37
- 238000004590 computer program Methods 0.000 claims description 36
- 238000004422 calculation algorithm Methods 0.000 claims description 35
- 238000004519 manufacturing process Methods 0.000 claims description 34
- 125000000539 amino acid group Chemical group 0.000 claims description 33
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 30
- 238000003556 assay Methods 0.000 claims description 30
- 230000015572 biosynthetic process Effects 0.000 claims description 29
- 239000000872 buffer Substances 0.000 claims description 27
- 239000012530 fluid Substances 0.000 claims description 26
- 230000002210 biocatalytic effect Effects 0.000 claims description 24
- 108091034117 Oligonucleotide Proteins 0.000 claims description 20
- 239000000835 fiber Substances 0.000 claims description 20
- 230000014509 gene expression Effects 0.000 claims description 20
- 235000020357 syrup Nutrition 0.000 claims description 20
- 239000006188 syrup Substances 0.000 claims description 20
- 240000006394 Sorghum bicolor Species 0.000 claims description 18
- 235000011684 Sorghum saccharatum Nutrition 0.000 claims description 18
- 238000013500 data storage Methods 0.000 claims description 18
- 238000011282 treatment Methods 0.000 claims description 18
- 239000011942 biocatalyst Substances 0.000 claims description 17
- 239000013604 expression vector Substances 0.000 claims description 17
- 239000000126 substance Substances 0.000 claims description 17
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 16
- 240000008042 Zea mays Species 0.000 claims description 15
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 15
- 235000005822 corn Nutrition 0.000 claims description 15
- 238000002360 preparation method Methods 0.000 claims description 14
- 230000007423 decrease Effects 0.000 claims description 13
- 230000002255 enzymatic effect Effects 0.000 claims description 13
- 239000008103 glucose Substances 0.000 claims description 13
- 238000012360 testing method Methods 0.000 claims description 13
- 238000001727 in vivo Methods 0.000 claims description 12
- 238000002741 site-directed mutagenesis Methods 0.000 claims description 12
- 229920002774 Maltodextrin Polymers 0.000 claims description 11
- 238000003776 cleavage reaction Methods 0.000 claims description 11
- 230000007017 scission Effects 0.000 claims description 11
- 241000209140 Triticum Species 0.000 claims description 10
- 235000021307 Triticum Nutrition 0.000 claims description 10
- 239000003795 chemical substances by application Substances 0.000 claims description 10
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 9
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 claims description 9
- 241000209056 Secale Species 0.000 claims description 9
- 235000007238 Secale cereale Nutrition 0.000 claims description 9
- 235000009430 Thespesia populnea Nutrition 0.000 claims description 9
- 229910001424 calcium ion Inorganic materials 0.000 claims description 9
- 239000005913 Maltodextrin Substances 0.000 claims description 8
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 8
- 238000007845 assembly PCR Methods 0.000 claims description 8
- 238000009990 desizing Methods 0.000 claims description 8
- 230000007062 hydrolysis Effects 0.000 claims description 8
- 238000006460 hydrolysis reaction Methods 0.000 claims description 8
- 229940035034 maltodextrin Drugs 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 8
- 230000001568 sexual effect Effects 0.000 claims description 8
- 239000004753 textile Substances 0.000 claims description 8
- 229920001131 Pulp (paper) Polymers 0.000 claims description 7
- 239000002253 acid Substances 0.000 claims description 7
- 239000007795 chemical reaction product Substances 0.000 claims description 7
- 239000007787 solid Substances 0.000 claims description 7
- 241000701161 unidentified adenovirus Species 0.000 claims description 7
- 241000894006 Bacteria Species 0.000 claims description 6
- 241001465754 Metazoa Species 0.000 claims description 6
- 240000007594 Oryza sativa Species 0.000 claims description 6
- 235000007164 Oryza sativa Nutrition 0.000 claims description 6
- 238000012219 cassette mutagenesis Methods 0.000 claims description 6
- 239000002761 deinking Substances 0.000 claims description 6
- 239000003599 detergent Substances 0.000 claims description 6
- 238000002955 isolation Methods 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 235000009566 rice Nutrition 0.000 claims description 6
- 238000005406 washing Methods 0.000 claims description 6
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 5
- 241000196324 Embryophyta Species 0.000 claims description 5
- 230000004075 alteration Effects 0.000 claims description 5
- 108010019077 beta-Amylase Proteins 0.000 claims description 5
- 239000004067 bulking agent Substances 0.000 claims description 5
- 239000011575 calcium Substances 0.000 claims description 5
- 229910052791 calcium Inorganic materials 0.000 claims description 5
- 235000013373 food additive Nutrition 0.000 claims description 5
- 239000002778 food additive Substances 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- 230000003647 oxidation Effects 0.000 claims description 5
- 238000007254 oxidation reaction Methods 0.000 claims description 5
- 239000002562 thickening agent Substances 0.000 claims description 5
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims description 4
- 108091006629 SLC13A2 Proteins 0.000 claims description 4
- 239000000654 additive Substances 0.000 claims description 4
- 230000000996 additive effect Effects 0.000 claims description 4
- 230000015556 catabolic process Effects 0.000 claims description 4
- 102000054765 polymorphisms of proteins Human genes 0.000 claims description 4
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 3
- 241000206602 Eukaryota Species 0.000 claims description 3
- 241000233866 Fungi Species 0.000 claims description 3
- 240000005979 Hordeum vulgare Species 0.000 claims description 3
- 235000007340 Hordeum vulgare Nutrition 0.000 claims description 3
- 244000017020 Ipomoea batatas Species 0.000 claims description 3
- 235000002678 Ipomoea batatas Nutrition 0.000 claims description 3
- 210000004507 artificial chromosome Anatomy 0.000 claims description 3
- 230000003301 hydrolyzing effect Effects 0.000 claims description 3
- 235000021374 legumes Nutrition 0.000 claims description 3
- 238000005086 pumping Methods 0.000 claims description 3
- 239000013603 viral vector Substances 0.000 claims 4
- 108020004711 Nucleic Acid Probes Proteins 0.000 claims 2
- 108010009736 Protein Hydrolysates Proteins 0.000 claims 2
- 239000000413 hydrolysate Substances 0.000 claims 2
- 230000000155 isotopic effect Effects 0.000 claims 2
- 239000002853 nucleic acid probe Substances 0.000 claims 2
- 239000013600 plasmid vector Substances 0.000 claims 2
- 230000003362 replicative effect Effects 0.000 claims 2
- 230000001177 retroviral effect Effects 0.000 claims 2
- 241001515965 unidentified phage Species 0.000 claims 2
- 108010005636 polypeptide C Proteins 0.000 claims 1
- 230000002378 acidificating effect Effects 0.000 abstract description 4
- 235000001014 amino acid Nutrition 0.000 description 154
- 229940024606 amino acid Drugs 0.000 description 139
- 230000008569 process Effects 0.000 description 90
- GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 description 74
- 235000018102 proteins Nutrition 0.000 description 57
- 238000009396 hybridization Methods 0.000 description 50
- 239000000243 solution Substances 0.000 description 48
- 229940025131 amylases Drugs 0.000 description 34
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 33
- 239000000725 suspension Substances 0.000 description 30
- 239000000047 product Substances 0.000 description 29
- 239000002609 medium Substances 0.000 description 26
- 238000012216 screening Methods 0.000 description 26
- 230000035772 mutation Effects 0.000 description 23
- 230000006798 recombination Effects 0.000 description 23
- 238000005215 recombination Methods 0.000 description 22
- 230000002829 reductive effect Effects 0.000 description 21
- 238000006467 substitution reaction Methods 0.000 description 21
- 150000001875 compounds Chemical class 0.000 description 20
- 229920001817 Agar Polymers 0.000 description 19
- 108020004705 Codon Proteins 0.000 description 19
- 239000008272 agar Substances 0.000 description 19
- 239000013612 plasmid Substances 0.000 description 19
- 238000010790 dilution Methods 0.000 description 18
- 239000012895 dilution Substances 0.000 description 18
- 238000012900 molecular simulation Methods 0.000 description 18
- 241000588724 Escherichia coli Species 0.000 description 16
- 239000007858 starting material Substances 0.000 description 16
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 15
- 238000007792 addition Methods 0.000 description 15
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 15
- 238000012217 deletion Methods 0.000 description 15
- 230000037430 deletion Effects 0.000 description 15
- 108091008053 gene clusters Proteins 0.000 description 14
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 13
- 108010076504 Protein Sorting Signals Proteins 0.000 description 13
- 230000006870 function Effects 0.000 description 13
- 230000037361 pathway Effects 0.000 description 13
- 230000007613 environmental effect Effects 0.000 description 12
- 238000005755 formation reaction Methods 0.000 description 12
- 125000000524 functional group Chemical group 0.000 description 12
- 230000001580 bacterial effect Effects 0.000 description 11
- 239000008187 granular material Substances 0.000 description 11
- 238000003786 synthesis reaction Methods 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 108091026890 Coding region Proteins 0.000 description 10
- 230000003321 amplification Effects 0.000 description 10
- 238000004458 analytical method Methods 0.000 description 10
- 238000013461 design Methods 0.000 description 10
- 238000003199 nucleic acid amplification method Methods 0.000 description 10
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 9
- 108091092195 Intron Proteins 0.000 description 9
- 238000013459 approach Methods 0.000 description 9
- 230000004071 biological effect Effects 0.000 description 9
- 230000002068 genetic effect Effects 0.000 description 9
- 238000012545 processing Methods 0.000 description 9
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 8
- 108010068370 Glutens Proteins 0.000 description 8
- 102000004157 Hydrolases Human genes 0.000 description 8
- 108090000604 Hydrolases Proteins 0.000 description 8
- 238000010586 diagram Methods 0.000 description 8
- 239000003623 enhancer Substances 0.000 description 8
- 235000021312 gluten Nutrition 0.000 description 8
- 244000005700 microbiome Species 0.000 description 8
- 238000013518 transcription Methods 0.000 description 8
- 230000035897 transcription Effects 0.000 description 8
- 241000194108 Bacillus licheniformis Species 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 7
- 239000000356 contaminant Substances 0.000 description 7
- 210000003527 eukaryotic cell Anatomy 0.000 description 7
- 238000010438 heat treatment Methods 0.000 description 7
- 229910052757 nitrogen Inorganic materials 0.000 description 7
- 241000894007 species Species 0.000 description 7
- 239000006228 supernatant Substances 0.000 description 7
- 239000008001 CAPS buffer Substances 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 239000006285 cell suspension Substances 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- 238000010367 cloning Methods 0.000 description 6
- 230000003247 decreasing effect Effects 0.000 description 6
- 230000029087 digestion Effects 0.000 description 6
- -1 expression vectors Chemical class 0.000 description 6
- 230000002349 favourable effect Effects 0.000 description 6
- 238000000338 in vitro Methods 0.000 description 6
- 239000011159 matrix material Substances 0.000 description 6
- 230000001404 mediated effect Effects 0.000 description 6
- 238000000746 purification Methods 0.000 description 6
- 238000003260 vortexing Methods 0.000 description 6
- 229920000945 Amylopectin Polymers 0.000 description 5
- 229920001353 Dextrin Polymers 0.000 description 5
- 239000004375 Dextrin Substances 0.000 description 5
- 229920002245 Dextrose equivalent Polymers 0.000 description 5
- 108700026244 Open Reading Frames Proteins 0.000 description 5
- 108010030975 Polyketide Synthases Proteins 0.000 description 5
- 239000004098 Tetracycline Substances 0.000 description 5
- 239000012472 biological sample Substances 0.000 description 5
- 239000003054 catalyst Substances 0.000 description 5
- 238000004113 cell culture Methods 0.000 description 5
- 235000013339 cereals Nutrition 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 230000001186 cumulative effect Effects 0.000 description 5
- 238000006911 enzymatic reaction Methods 0.000 description 5
- 239000000499 gel Substances 0.000 description 5
- 230000001976 improved effect Effects 0.000 description 5
- 239000006166 lysate Substances 0.000 description 5
- 238000002844 melting Methods 0.000 description 5
- 230000008018 melting Effects 0.000 description 5
- 231100000219 mutagenic Toxicity 0.000 description 5
- 230000003505 mutagenic effect Effects 0.000 description 5
- 229920001542 oligosaccharide Polymers 0.000 description 5
- 150000002482 oligosaccharides Chemical class 0.000 description 5
- 238000011084 recovery Methods 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- 230000010076 replication Effects 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 108091008146 restriction endonucleases Proteins 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- 238000007423 screening assay Methods 0.000 description 5
- 238000012163 sequencing technique Methods 0.000 description 5
- 235000000346 sugar Nutrition 0.000 description 5
- 235000019364 tetracycline Nutrition 0.000 description 5
- 150000003522 tetracyclines Chemical class 0.000 description 5
- 238000001890 transfection Methods 0.000 description 5
- 238000012546 transfer Methods 0.000 description 5
- 238000013519 translation Methods 0.000 description 5
- 230000014616 translation Effects 0.000 description 5
- 238000011179 visual inspection Methods 0.000 description 5
- 229920000856 Amylose Polymers 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 102000053602 DNA Human genes 0.000 description 4
- 239000006137 Luria-Bertani broth Substances 0.000 description 4
- 108700005078 Synthetic Genes Proteins 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 230000001851 biosynthetic effect Effects 0.000 description 4
- 230000003197 catalytic effect Effects 0.000 description 4
- 235000019425 dextrin Nutrition 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 238000001502 gel electrophoresis Methods 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 125000001475 halogen functional group Chemical group 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 238000009630 liquid culture Methods 0.000 description 4
- 210000004962 mammalian cell Anatomy 0.000 description 4
- 238000010369 molecular cloning Methods 0.000 description 4
- 230000036961 partial effect Effects 0.000 description 4
- 238000010647 peptide synthesis reaction Methods 0.000 description 4
- 230000008488 polyadenylation Effects 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- 210000001236 prokaryotic cell Anatomy 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- 239000007790 solid phase Substances 0.000 description 4
- 150000008163 sugars Chemical class 0.000 description 4
- 229960002180 tetracycline Drugs 0.000 description 4
- 229930101283 tetracycline Natural products 0.000 description 4
- 238000001238 wet grinding Methods 0.000 description 4
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 3
- 241000972773 Aulopiformes Species 0.000 description 3
- 241000193830 Bacillus <bacterium> Species 0.000 description 3
- 108020004635 Complementary DNA Proteins 0.000 description 3
- 108020005124 DNA Adducts Proteins 0.000 description 3
- 108700024394 Exon Proteins 0.000 description 3
- 229930091371 Fructose Natural products 0.000 description 3
- 239000005715 Fructose Substances 0.000 description 3
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 3
- 241000193385 Geobacillus stearothermophilus Species 0.000 description 3
- 241000238631 Hexapoda Species 0.000 description 3
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 3
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 3
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 3
- 102000035195 Peptidases Human genes 0.000 description 3
- 108091005804 Peptidases Proteins 0.000 description 3
- 239000004365 Protease Substances 0.000 description 3
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 3
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 3
- 108091081062 Repeated sequence (DNA) Proteins 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 241000187747 Streptomyces Species 0.000 description 3
- 108010006785 Taq Polymerase Proteins 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 239000011543 agarose gel Substances 0.000 description 3
- 229960000723 ampicillin Drugs 0.000 description 3
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 3
- 210000004436 artificial bacterial chromosome Anatomy 0.000 description 3
- 239000011324 bead Substances 0.000 description 3
- 235000012180 bread and bread product Nutrition 0.000 description 3
- 239000007853 buffer solution Substances 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 239000013599 cloning vector Substances 0.000 description 3
- 238000011109 contamination Methods 0.000 description 3
- 239000002285 corn oil Substances 0.000 description 3
- 235000005687 corn oil Nutrition 0.000 description 3
- 239000013601 cosmid vector Substances 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 239000008121 dextrose Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000009837 dry grinding Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000005284 excitation Effects 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 239000011888 foil Substances 0.000 description 3
- 230000002538 fungal effect Effects 0.000 description 3
- 230000004927 fusion Effects 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 229960000318 kanamycin Drugs 0.000 description 3
- 229930027917 kanamycin Natural products 0.000 description 3
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 3
- 229930182823 kanamycin A Natural products 0.000 description 3
- 238000002372 labelling Methods 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 235000012054 meals Nutrition 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 108020004999 messenger RNA Proteins 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 239000002751 oligonucleotide probe Substances 0.000 description 3
- 229930001119 polyketide Natural products 0.000 description 3
- 125000000830 polyketide group Chemical group 0.000 description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
- 230000002285 radioactive effect Effects 0.000 description 3
- 230000008521 reorganization Effects 0.000 description 3
- 230000000717 retained effect Effects 0.000 description 3
- 235000019515 salmon Nutrition 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- DBTMGCOVALSLOR-UHFFFAOYSA-N 32-alpha-galactosyl-3-alpha-galactosyl-galactose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(OC2C(C(CO)OC(O)C2O)O)OC(CO)C1O DBTMGCOVALSLOR-UHFFFAOYSA-N 0.000 description 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 2
- 241000228212 Aspergillus Species 0.000 description 2
- 244000063299 Bacillus subtilis Species 0.000 description 2
- 235000014469 Bacillus subtilis Nutrition 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 241000282693 Cercopithecidae Species 0.000 description 2
- 229920002261 Corn starch Polymers 0.000 description 2
- RXVWSYJTUUKTEA-UHFFFAOYSA-N D-maltotriose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 RXVWSYJTUUKTEA-UHFFFAOYSA-N 0.000 description 2
- 108010017826 DNA Polymerase I Proteins 0.000 description 2
- 102000004594 DNA Polymerase I Human genes 0.000 description 2
- 230000006820 DNA synthesis Effects 0.000 description 2
- 229920002307 Dextran Polymers 0.000 description 2
- 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 2
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- 108091029865 Exogenous DNA Proteins 0.000 description 2
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 2
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 2
- 102100022624 Glucoamylase Human genes 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
- 102000004882 Lipase Human genes 0.000 description 2
- 108090001060 Lipase Proteins 0.000 description 2
- 239000004367 Lipase Substances 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- 101710117655 Maltogenic alpha-amylase Proteins 0.000 description 2
- 101000969137 Mus musculus Metallothionein-1 Proteins 0.000 description 2
- 229930193140 Neomycin Natural products 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 108091093037 Peptide nucleic acid Proteins 0.000 description 2
- 108700020962 Peroxidase Proteins 0.000 description 2
- 102000003992 Peroxidases Human genes 0.000 description 2
- 108091000080 Phosphotransferase Proteins 0.000 description 2
- 241000589516 Pseudomonas Species 0.000 description 2
- 108020004511 Recombinant DNA Proteins 0.000 description 2
- 108020005091 Replication Origin Proteins 0.000 description 2
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 2
- 238000012300 Sequence Analysis Methods 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 244000061456 Solanum tuberosum Species 0.000 description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 description 2
- 241000256248 Spodoptera Species 0.000 description 2
- 108010022394 Threonine synthase Proteins 0.000 description 2
- 102000006601 Thymidine Kinase Human genes 0.000 description 2
- 108020004440 Thymidine kinase Proteins 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 108091023045 Untranslated Region Proteins 0.000 description 2
- 206010046865 Vaccinia virus infection Diseases 0.000 description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
- 108020005202 Viral DNA Proteins 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 229960000643 adenine Drugs 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- 125000003368 amide group Chemical group 0.000 description 2
- 210000004102 animal cell Anatomy 0.000 description 2
- 230000000692 anti-sense effect Effects 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 235000009582 asparagine Nutrition 0.000 description 2
- 229960001230 asparagine Drugs 0.000 description 2
- 235000003704 aspartic acid Nutrition 0.000 description 2
- 238000000376 autoradiography Methods 0.000 description 2
- 235000015173 baked goods and baking mixes Nutrition 0.000 description 2
- 238000002869 basic local alignment search tool Methods 0.000 description 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 230000002902 bimodal effect Effects 0.000 description 2
- 230000008238 biochemical pathway Effects 0.000 description 2
- 238000005842 biochemical reaction Methods 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- DMVOXQPQNTYEKQ-UHFFFAOYSA-N biphenyl-4-amine Chemical group C1=CC(N)=CC=C1C1=CC=CC=C1 DMVOXQPQNTYEKQ-UHFFFAOYSA-N 0.000 description 2
- 235000008429 bread Nutrition 0.000 description 2
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 2
- 239000000920 calcium hydroxide Substances 0.000 description 2
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 229910000389 calcium phosphate Inorganic materials 0.000 description 2
- 235000011010 calcium phosphates Nutrition 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000007385 chemical modification Methods 0.000 description 2
- 230000002759 chromosomal effect Effects 0.000 description 2
- 210000000349 chromosome Anatomy 0.000 description 2
- 238000012411 cloning technique Methods 0.000 description 2
- 238000010960 commercial process Methods 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000008120 corn starch Substances 0.000 description 2
- 229940099112 cornstarch Drugs 0.000 description 2
- 238000012937 correction Methods 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000001212 derivatisation Methods 0.000 description 2
- 102000004419 dihydrofolate reductase Human genes 0.000 description 2
- 238000006073 displacement reaction Methods 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 238000004520 electroporation Methods 0.000 description 2
- 230000009088 enzymatic function Effects 0.000 description 2
- 108010052305 exodeoxyribonuclease III Proteins 0.000 description 2
- 238000013401 experimental design Methods 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 2
- 230000013595 glycosylation Effects 0.000 description 2
- 238000006206 glycosylation reaction Methods 0.000 description 2
- 238000002744 homologous recombination Methods 0.000 description 2
- 230000006801 homologous recombination Effects 0.000 description 2
- 210000004408 hybridoma Anatomy 0.000 description 2
- 238000005805 hydroxylation reaction Methods 0.000 description 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 2
- 229960000310 isoleucine Drugs 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 101150066555 lacZ gene Proteins 0.000 description 2
- 238000007834 ligase chain reaction Methods 0.000 description 2
- 235000019421 lipase Nutrition 0.000 description 2
- FYGDTMLNYKFZSV-UHFFFAOYSA-N mannotriose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(O)C(O)C2O)CO)C(O)C1O FYGDTMLNYKFZSV-UHFFFAOYSA-N 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 201000001441 melanoma Diseases 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- 239000003471 mutagenic agent Substances 0.000 description 2
- 229960004927 neomycin Drugs 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 238000007899 nucleic acid hybridization Methods 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 102000020233 phosphotransferase Human genes 0.000 description 2
- 230000001323 posttranslational effect Effects 0.000 description 2
- 229920001592 potato starch Polymers 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 230000000644 propagated effect Effects 0.000 description 2
- 230000001902 propagating effect Effects 0.000 description 2
- 230000002797 proteolythic effect Effects 0.000 description 2
- 208000009305 pseudorabies Diseases 0.000 description 2
- 239000011535 reaction buffer Substances 0.000 description 2
- 230000003252 repetitive effect Effects 0.000 description 2
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 2
- 238000007363 ring formation reaction Methods 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 238000002864 sequence alignment Methods 0.000 description 2
- 229960001153 serine Drugs 0.000 description 2
- 229940001593 sodium carbonate Drugs 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 229910000162 sodium phosphate Inorganic materials 0.000 description 2
- 239000008174 sterile solution Substances 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 230000009897 systematic effect Effects 0.000 description 2
- 230000002103 transcriptional effect Effects 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 230000014621 translational initiation Effects 0.000 description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- 241000701447 unidentified baculovirus Species 0.000 description 2
- 241001430294 unidentified retrovirus Species 0.000 description 2
- 208000007089 vaccinia Diseases 0.000 description 2
- 239000004474 valine Substances 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- FYGDTMLNYKFZSV-BYLHFPJWSA-N β-1,4-galactotrioside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-BYLHFPJWSA-N 0.000 description 2
- 125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 description 1
- GZCWLCBFPRFLKL-UHFFFAOYSA-N 1-prop-2-ynoxypropan-2-ol Chemical compound CC(O)COCC#C GZCWLCBFPRFLKL-UHFFFAOYSA-N 0.000 description 1
- ABEXEQSGABRUHS-UHFFFAOYSA-N 16-methylheptadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC(C)C ABEXEQSGABRUHS-UHFFFAOYSA-N 0.000 description 1
- MDSPECLCFVWIGQ-UHFFFAOYSA-N 2-bromoprop-2-enal Chemical compound BrC(=C)C=O MDSPECLCFVWIGQ-UHFFFAOYSA-N 0.000 description 1
- WDQMQAGPUAGBFL-UHFFFAOYSA-N 2-bromoprop-2-enal 1,2-dibromo-3-chloropropane Chemical compound BrC(C=O)=C.BrCC(CCl)Br WDQMQAGPUAGBFL-UHFFFAOYSA-N 0.000 description 1
- OSJPPGNTCRNQQC-UWTATZPHSA-N 3-phospho-D-glyceric acid Chemical compound OC(=O)[C@H](O)COP(O)(O)=O OSJPPGNTCRNQQC-UWTATZPHSA-N 0.000 description 1
- IRLPACMLTUPBCL-KQYNXXCUSA-N 5'-adenylyl sulfate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OS(O)(=O)=O)[C@@H](O)[C@H]1O IRLPACMLTUPBCL-KQYNXXCUSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- MHXSSKQMMHEKPM-UHFFFAOYSA-N 7-(bromomethyl)benzo[a]anthracene tris(2,3-dibromopropyl) phosphate Chemical compound BrC(COP(=O)(OCC(CBr)Br)OCC(CBr)Br)CBr.BrCC=1C2=CC=C3C(=C2C=C2C=CC=CC12)C=CC=C3 MHXSSKQMMHEKPM-UHFFFAOYSA-N 0.000 description 1
- STQGQHZAVUOBTE-UHFFFAOYSA-N 7-Cyan-hept-2t-en-4,6-diinsaeure Natural products C1=2C(O)=C3C(=O)C=4C(OC)=CC=CC=4C(=O)C3=C(O)C=2CC(O)(C(C)=O)CC1OC1CC(N)C(O)C(C)O1 STQGQHZAVUOBTE-UHFFFAOYSA-N 0.000 description 1
- 230000005730 ADP ribosylation Effects 0.000 description 1
- 102000013563 Acid Phosphatase Human genes 0.000 description 1
- 108010051457 Acid Phosphatase Proteins 0.000 description 1
- 108700028369 Alleles Proteins 0.000 description 1
- 108091023037 Aptamer Proteins 0.000 description 1
- 101100238293 Arabidopsis thaliana MOR1 gene Proteins 0.000 description 1
- 241000203069 Archaea Species 0.000 description 1
- 241000193744 Bacillus amyloliquefaciens Species 0.000 description 1
- 108090000994 Catalytic RNA Proteins 0.000 description 1
- 102000053642 Catalytic RNA Human genes 0.000 description 1
- 108010059892 Cellulase Proteins 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 108091062157 Cis-regulatory element Proteins 0.000 description 1
- 108091033380 Coding strand Proteins 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 241000701022 Cytomegalovirus Species 0.000 description 1
- ZCLAHGAZPPEVDX-UHFFFAOYSA-N D-panose Natural products OC1C(O)C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC1COC1C(O)C(O)C(O)C(CO)O1 ZCLAHGAZPPEVDX-UHFFFAOYSA-N 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 230000005778 DNA damage Effects 0.000 description 1
- 231100000277 DNA damage Toxicity 0.000 description 1
- 230000033616 DNA repair Effects 0.000 description 1
- 230000004543 DNA replication Effects 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- WEAHRLBPCANXCN-UHFFFAOYSA-N Daunomycin Natural products CCC1(O)CC(OC2CC(N)C(O)C(C)O2)c3cc4C(=O)c5c(OC)cccc5C(=O)c4c(O)c3C1 WEAHRLBPCANXCN-UHFFFAOYSA-N 0.000 description 1
- 238000012286 ELISA Assay Methods 0.000 description 1
- 108060002716 Exonuclease Proteins 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 241000700662 Fowlpox virus Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 108700028146 Genetic Enhancer Elements Proteins 0.000 description 1
- 102000005744 Glycoside Hydrolases Human genes 0.000 description 1
- 108010031186 Glycoside Hydrolases Proteins 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- 108700005087 Homeobox Genes Proteins 0.000 description 1
- 102000000589 Interleukin-1 Human genes 0.000 description 1
- 108010002352 Interleukin-1 Proteins 0.000 description 1
- 241000764238 Isis Species 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 108090001090 Lectins Proteins 0.000 description 1
- 102000004856 Lectins Human genes 0.000 description 1
- 241001599018 Melanogaster Species 0.000 description 1
- 241000203407 Methanocaldococcus jannaschii Species 0.000 description 1
- 229930191564 Monensin Natural products 0.000 description 1
- GAOZTHIDHYLHMS-UHFFFAOYSA-N Monensin A Natural products O1C(CC)(C2C(CC(O2)C2C(CC(C)C(O)(CO)O2)C)C)CCC1C(O1)(C)CCC21CC(O)C(C)C(C(C)C(OC)C(C)C(O)=O)O2 GAOZTHIDHYLHMS-UHFFFAOYSA-N 0.000 description 1
- 102000006833 Multifunctional Enzymes Human genes 0.000 description 1
- 108010047290 Multifunctional Enzymes Proteins 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699660 Mus musculus Species 0.000 description 1
- 241000204051 Mycoplasma genitalium Species 0.000 description 1
- QYFQSQCBYZOECM-UHFFFAOYSA-N N-Hydroxy-IQ Chemical compound C1=CC2=NC=CC=C2C2=C1N(C)C(NO)=N2 QYFQSQCBYZOECM-UHFFFAOYSA-N 0.000 description 1
- DCVWQAGUQFBCTF-UHFFFAOYSA-N N-hydroxy-PhIP Chemical compound C1=C2N(C)C(NO)=NC2=NC=C1C1=CC=CC=C1 DCVWQAGUQFBCTF-UHFFFAOYSA-N 0.000 description 1
- 238000000636 Northern blotting Methods 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241000276498 Pollachius virens Species 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 241000589540 Pseudomonas fluorescens Species 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- 230000006819 RNA synthesis Effects 0.000 description 1
- 102000001218 Rec A Recombinases Human genes 0.000 description 1
- 108010055016 Rec A Recombinases Proteins 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 241000231739 Rutilus rutilus Species 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 102100038803 Somatotropin Human genes 0.000 description 1
- 238000002105 Southern blotting Methods 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 108091081024 Start codon Proteins 0.000 description 1
- 208000037065 Subacute sclerosing leukoencephalitis Diseases 0.000 description 1
- 206010042297 Subacute sclerosing panencephalitis Diseases 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 101150006914 TRP1 gene Proteins 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- 102000040945 Transcription factor Human genes 0.000 description 1
- 108020004566 Transfer RNA Proteins 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- PQYJRMFWJJONBO-UHFFFAOYSA-N Tris(2,3-dibromopropyl) phosphate Chemical compound BrCC(Br)COP(=O)(OCC(Br)CBr)OCC(Br)CBr PQYJRMFWJJONBO-UHFFFAOYSA-N 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 241000482268 Zea mays subsp. mays Species 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 150000001241 acetals Chemical class 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 230000009435 amidation Effects 0.000 description 1
- 238000007112 amidation reaction Methods 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 230000006229 amino acid addition Effects 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 238000012870 ammonium sulfate precipitation Methods 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 230000003625 amylolytic effect Effects 0.000 description 1
- 238000004873 anchoring Methods 0.000 description 1
- 238000005571 anion exchange chromatography Methods 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000000637 arginyl group Chemical class N[C@@H](CCCNC(N)=N)C(=O)* 0.000 description 1
- 230000010516 arginylation Effects 0.000 description 1
- 238000013528 artificial neural network Methods 0.000 description 1
- 210000001106 artificial yeast chromosome Anatomy 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 125000005605 benzo group Chemical group 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 238000012742 biochemical analysis Methods 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 238000006664 bond formation reaction Methods 0.000 description 1
- 235000012813 breadcrumbs Nutrition 0.000 description 1
- 238000013124 brewing process Methods 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 238000005277 cation exchange chromatography Methods 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000033077 cellular process Effects 0.000 description 1
- 229940106157 cellulase Drugs 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- 150000001844 chromium Chemical class 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 239000003245 coal Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000001332 colony forming effect Effects 0.000 description 1
- 238000010835 comparative analysis Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000008139 complexing agent Substances 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 229910000366 copper(II) sulfate Inorganic materials 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 1
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 1
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 1
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 1
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- STQGQHZAVUOBTE-VGBVRHCVSA-N daunorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(C)=O)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 STQGQHZAVUOBTE-VGBVRHCVSA-N 0.000 description 1
- 230000017858 demethylation Effects 0.000 description 1
- 238000010520 demethylation reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- AUPXFICLXPLHBB-UHFFFAOYSA-L disodium;2-(4-carboxylatoquinolin-2-yl)quinoline-4-carboxylate Chemical compound [Na+].[Na+].C1=CC=CC2=NC(C=3C=C(C4=CC=CC=C4N=3)C(=O)[O-])=CC(C([O-])=O)=C21 AUPXFICLXPLHBB-UHFFFAOYSA-L 0.000 description 1
- MQRJBSHKWOFOGF-UHFFFAOYSA-L disodium;carbonate;hydrate Chemical compound O.[Na+].[Na+].[O-]C([O-])=O MQRJBSHKWOFOGF-UHFFFAOYSA-L 0.000 description 1
- 238000005553 drilling Methods 0.000 description 1
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- 238000011067 equilibration Methods 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 229960005542 ethidium bromide Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 102000013165 exonuclease Human genes 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000008713 feedback mechanism Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012847 fine chemical Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000005188 flotation Methods 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 238000001943 fluorescence-activated cell sorting Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000022244 formylation Effects 0.000 description 1
- 238000006170 formylation reaction Methods 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 230000006251 gamma-carboxylation Effects 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 101150056310 gem1 gene Proteins 0.000 description 1
- 238000012268 genome sequencing Methods 0.000 description 1
- 230000002414 glycolytic effect Effects 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 150000003278 haem Chemical group 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 235000006486 human diet Nutrition 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000004191 hydrophobic interaction chromatography Methods 0.000 description 1
- 238000012872 hydroxylapatite chromatography Methods 0.000 description 1
- 230000033444 hydroxylation Effects 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 238000005417 image-selected in vivo spectroscopy Methods 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 238000012739 integrated shape imaging system Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000026045 iodination Effects 0.000 description 1
- 238000006192 iodination reaction Methods 0.000 description 1
- 238000006317 isomerization reaction Methods 0.000 description 1
- 101150109249 lacI gene Proteins 0.000 description 1
- 150000002611 lead compounds Chemical class 0.000 description 1
- 239000002523 lectin Substances 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 238000001638 lipofection Methods 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 238000002761 liquid phase assay Methods 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 238000002865 local sequence alignment Methods 0.000 description 1
- 230000002934 lysing effect Effects 0.000 description 1
- 230000002132 lysosomal effect Effects 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 229960005358 monensin Drugs 0.000 description 1
- GAOZTHIDHYLHMS-KEOBGNEYSA-N monensin A Chemical compound C([C@@](O1)(C)[C@H]2CC[C@@](O2)(CC)[C@H]2[C@H](C[C@@H](O2)[C@@H]2[C@H](C[C@@H](C)[C@](O)(CO)O2)C)C)C[C@@]21C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H](OC)[C@H](C)C(O)=O)O2 GAOZTHIDHYLHMS-KEOBGNEYSA-N 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 238000002887 multiple sequence alignment Methods 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 238000011275 oncology therapy Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- HFHZKZSRXITVMK-UHFFFAOYSA-N oxyphenbutazone Chemical compound O=C1C(CCCC)C(=O)N(C=2C=CC=CC=2)N1C1=CC=C(O)C=C1 HFHZKZSRXITVMK-UHFFFAOYSA-N 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- ZCLAHGAZPPEVDX-MQHGYYCBSA-N panose Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@@H](O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)C=O)O[C@@H]1CO[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 ZCLAHGAZPPEVDX-MQHGYYCBSA-N 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 229940080469 phosphocellulose Drugs 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 230000010287 polarization Effects 0.000 description 1
- 229920005547 polycyclic aromatic hydrocarbon Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920005597 polymer membrane Polymers 0.000 description 1
- XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 description 1
- 230000013823 prenylation Effects 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000009145 protein modification Effects 0.000 description 1
- 230000030788 protein refolding Effects 0.000 description 1
- 230000018883 protein targeting Effects 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 1
- 229940043131 pyroglutamate Drugs 0.000 description 1
- 230000006340 racemization Effects 0.000 description 1
- 238000003127 radioimmunoassay Methods 0.000 description 1
- 238000002708 random mutagenesis Methods 0.000 description 1
- ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000010832 regulated medical waste Substances 0.000 description 1
- 108091035233 repetitive DNA sequence Proteins 0.000 description 1
- 102000053632 repetitive DNA sequence Human genes 0.000 description 1
- 210000001995 reticulocyte Anatomy 0.000 description 1
- 108091092562 ribozyme Proteins 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000002804 saturated mutagenesis Methods 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000010801 sewage sludge Substances 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 229960002930 sirolimus Drugs 0.000 description 1
- QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229940076133 sodium carbonate monohydrate Drugs 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 235000011008 sodium phosphates Nutrition 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 238000010972 statistical evaluation Methods 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 230000019635 sulfation Effects 0.000 description 1
- 238000005670 sulfation reaction Methods 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 229940040944 tetracyclines Drugs 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical class CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000010361 transduction Methods 0.000 description 1
- 230000026683 transduction Effects 0.000 description 1
- 238000011830 transgenic mouse model Methods 0.000 description 1
- 230000005945 translocation Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 150000004043 trisaccharides Chemical class 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 230000034512 ubiquitination Effects 0.000 description 1
- 238000010798 ubiquitination Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
- 235000020985 whole grains Nutrition 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
- C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
- C12N9/2411—Amylases
- C12N9/2414—Alpha-amylase (3.2.1.1.)
- C12N9/2417—Alpha-amylase (3.2.1.1.) from microbiological source
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS
- A21D8/00—Methods for preparing or baking dough
- A21D8/02—Methods for preparing dough; Treating dough prior to baking
- A21D8/04—Methods for preparing dough; Treating dough prior to baking treating dough with microorganisms or enzymes
- A21D8/042—Methods for preparing dough; Treating dough prior to baking treating dough with microorganisms or enzymes with enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
- C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
- C12N9/2411—Amylases
- C12N9/2414—Alpha-amylase (3.2.1.1.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/14—Preparation of compounds containing saccharide radicals produced by the action of a carbohydrase (EC 3.2.x), e.g. by alpha-amylase, e.g. by cellulase, hemicellulase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01001—Alpha-amylase (3.2.1.1)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
- Y02E50/00—Technologies for the production of fuel of non-fossil origin
- Y02E50/10—Biofuels, e.g. bio-diesel
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Cereal-Derived Products (AREA)
- Bakery Products And Manufacturing Methods Therefor (AREA)
- Fodder In General (AREA)
- Paper (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Detergent Compositions (AREA)
- Alcoholic Beverages (AREA)
- Chemical Or Physical Treatment Of Fibers (AREA)
- Jellies, Jams, And Syrups (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2006201514A AU2006201514B2 (en) | 2001-02-21 | 2006-04-11 | Enzymes having alpha amylase activity and methods of use thereof |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27049501P | 2001-02-21 | 2001-02-21 | |
| US27049601P | 2001-02-21 | 2001-02-21 | |
| US60/270,495 | 2001-02-21 | ||
| US60/270,496 | 2001-02-21 | ||
| US29112201P | 2001-05-14 | 2001-05-14 | |
| US60/291,122 | 2001-05-14 | ||
| PCT/US2002/005538 WO2002068597A2 (en) | 2001-02-21 | 2002-02-21 | Enzymes having alpha amylase activity and methods of use thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2006201514A Division AU2006201514B2 (en) | 2001-02-21 | 2006-04-11 | Enzymes having alpha amylase activity and methods of use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| AU2002240489A1 AU2002240489A1 (en) | 2003-03-06 |
| AU2002240489B2 AU2002240489B2 (en) | 2006-01-12 |
| AU2002240489C1 true AU2002240489C1 (en) | 2009-02-05 |
Family
ID=27402294
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002240489A Ceased AU2002240489C1 (en) | 2001-02-21 | 2002-02-21 | Enzymes having alpha amylase activity and methods of use thereof |
| AU2006207843A Ceased AU2006207843C1 (en) | 2001-02-21 | 2006-09-04 | Enzymes having alpha amylase activity and method of use thereof |
| AU2009222426A Ceased AU2009222426B2 (en) | 2001-02-21 | 2009-09-25 | Enzymes having alpha amylase activity and methods of use thereof |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2006207843A Ceased AU2006207843C1 (en) | 2001-02-21 | 2006-09-04 | Enzymes having alpha amylase activity and method of use thereof |
| AU2009222426A Ceased AU2009222426B2 (en) | 2001-02-21 | 2009-09-25 | Enzymes having alpha amylase activity and methods of use thereof |
Country Status (15)
| Country | Link |
|---|---|
| US (10) | US7273740B2 (enExample) |
| EP (8) | EP2333097B1 (enExample) |
| JP (9) | JP2004533219A (enExample) |
| CN (3) | CN104593394A (enExample) |
| AT (1) | ATE510023T1 (enExample) |
| AU (3) | AU2002240489C1 (enExample) |
| BR (1) | BRPI0207770A8 (enExample) |
| CA (6) | CA2833423C (enExample) |
| CY (1) | CY1111771T1 (enExample) |
| DK (4) | DK2333099T3 (enExample) |
| ES (4) | ES2613277T3 (enExample) |
| MX (1) | MXPA03007527A (enExample) |
| PT (1) | PT1370674E (enExample) |
| WO (2) | WO2002068589A2 (enExample) |
| ZA (2) | ZA200306486B (enExample) |
Families Citing this family (100)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1141275B1 (en) * | 1999-01-05 | 2009-08-12 | Trustees Of Boston University | Improved nucleic acid cloning |
| US20040005673A1 (en) * | 2001-06-29 | 2004-01-08 | Kevin Jarrell | System for manipulating nucleic acids |
| WO2002008408A2 (en) * | 2000-07-21 | 2002-01-31 | Trustees Of Boston University | Modular vector systems |
| US7435562B2 (en) | 2000-07-21 | 2008-10-14 | Modular Genetics, Inc. | Modular vector systems |
| AU2001287643A1 (en) | 2000-07-28 | 2002-02-13 | Henkel Kommanditgesellschaft Auf Aktien | Novel amylolytic enzyme extracted from bacillus SP. A 7-7 (DSM 12368) and washing and cleaning agents containing this novel amylolytic enzyme |
| CA2833423C (en) * | 2001-02-21 | 2019-03-19 | Verenium Corporation | Enzymes having alpha amylase activity and methods of use thereof |
| US7560126B2 (en) | 2001-02-21 | 2009-07-14 | Verenium Corporation | Amylases, nucleic acids encoding them and methods for making and using them |
| US7659102B2 (en) | 2001-02-21 | 2010-02-09 | Verenium Corporation | Amylases, nucleic acids encoding them and methods for making and using them |
| DE10138753B4 (de) * | 2001-08-07 | 2017-07-20 | Henkel Ag & Co. Kgaa | Wasch- und Reinigungsmittel mit Hybrid-Alpha-Amylasen |
| EP1432798B1 (en) | 2001-08-27 | 2010-11-17 | Syngenta Participations AG | Self-processing plants and plant parts |
| AU2003285906A1 (en) | 2002-10-31 | 2004-06-07 | Diversa Corporation | Amylases, nucleic acids encoding them and methods for making and using them |
| DE60310264T2 (de) | 2002-12-17 | 2007-07-05 | Novozymes A/S | Thermostabile alpha-amylase |
| ES2713024T3 (es) * | 2003-03-06 | 2019-05-17 | Basf Enzymes Llc | Amilasas, ácidos nucleicos que las codifican y métodos para su fabricación y uso |
| BRPI0408158A8 (pt) * | 2003-03-06 | 2017-12-05 | Diversa Corp | Amilases, ácidos nucléicos codificando-as e métodos para preparar e empregá-las |
| AU2015218541A1 (en) * | 2003-03-06 | 2015-10-29 | Basf Enzymes Llc | Amylases, nucleic acids encoding them and methods for making and using them |
| NZ541813A (en) * | 2003-03-10 | 2006-12-22 | Genencor Int | Grain compositions containing isomalto-oligosaccharides and methods for making the same; the method includes the derivation of the isomalto-oligosaccharides from the starch contained within the grain |
| PL1654355T3 (pl) * | 2003-06-13 | 2010-09-30 | Dupont Nutrition Biosci Aps | Warianty polipeptydów Pseudomonas o aktywności niemaltogennej egzoamylazy i ich zastosowanie do wytwarzania produktów żywnościowych |
| US7618795B2 (en) | 2003-06-25 | 2009-11-17 | Novozymes A/S | Starch process |
| CA2538349C (en) | 2003-06-25 | 2014-08-12 | Novozymes A/S | Polypeptides having alpha-amylase activity and polynucleotides encoding same |
| WO2004113551A1 (en) | 2003-06-25 | 2004-12-29 | Novozymes A/S | Process for the hydrolysis of starch |
| AU2004258115A1 (en) | 2003-07-07 | 2005-01-27 | Danisco A/S | Thermostable amylase polypeptides, nucleic acids encoding those polypeptides and uses thereof |
| US8143048B2 (en) | 2003-07-07 | 2012-03-27 | Danisco A/S | Exo-specific amylase polypeptides, nucleic acids encoding those polypeptides and uses thereof |
| US7169257B2 (en) * | 2003-11-12 | 2007-01-30 | Kemira Chemicals, Inc. | Method of deinking waste paper using a reduced alkali system |
| AU2004318207B2 (en) * | 2004-03-08 | 2009-12-17 | Syngenta Participations Ag | Self-processing plants and plant parts |
| US20050257932A1 (en) * | 2004-05-19 | 2005-11-24 | Davidson Eric A | Filter cake degradation compositions and associated methods |
| DK2295557T3 (en) * | 2004-07-07 | 2017-12-11 | Genencor Int | EXOAMYLASE VARIANTS |
| AU2011203198B2 (en) * | 2004-07-07 | 2013-01-10 | Dupont Nutrition Biosciences Aps | Polypeptide |
| US20060084150A1 (en) * | 2004-09-29 | 2006-04-20 | Qunyu Gao | Method for manufacturing maltose-rich products |
| CA2590245A1 (en) * | 2004-11-11 | 2006-05-18 | Modular Genetics, Inc. | Ladder assembly and system for generating diversity |
| AU2005318698A1 (en) | 2004-12-22 | 2006-06-29 | Novozymes A/S | Hybrid enzymes consisting of an endo-amylase first amino acid sequence and a carbohydrate -binding module as second amino acid sequence |
| US20060147581A1 (en) | 2004-12-22 | 2006-07-06 | Novozymes A/S | Hybrid enzymes |
| PT1868426T (pt) * | 2005-03-16 | 2018-05-08 | Syngenta Participations Ag | Evento de milho 3272 e métodos para a sua deteção |
| US20070184472A1 (en) * | 2005-06-08 | 2007-08-09 | Toagosei Co., Ltd | Method of purifying environmental dna and method of efficiently screening for protein-encoding gene from environmental dna |
| US8030050B2 (en) | 2005-07-07 | 2011-10-04 | Danisco A/S | Modified amylases from Pseudomonas species |
| NZ573564A (en) | 2006-06-19 | 2012-01-12 | Danisco | PS4 variant polypeptide with amylase activity |
| WO2008008808A2 (en) * | 2006-07-11 | 2008-01-17 | Modular Genetics Inc. | Methods of introducing targeted diversity into nucleic acid molecules |
| BRPI0714876B1 (pt) | 2006-08-04 | 2022-04-19 | Verenium Corporation | Ácido nucleico isolado, sintético ou recombinante, cassete de expressão, vetor ou veículo de clonagem, célula bacteriana, fúngica ou de levedura transformada, polipeptídeo isolado, sintético ou recombinante, composição, bem como métodos de produção e de usos dos mesmos |
| US7808342B2 (en) * | 2006-10-02 | 2010-10-05 | Skyworks Solutions, Inc. | Harmonic phase tuning filter for RF switches |
| WO2008080093A2 (en) | 2006-12-21 | 2008-07-03 | Verenium Corporation | Amylases and glucoamylases, nucleic acids encoding them and methods for making and using them |
| WO2008150880A1 (en) * | 2007-06-01 | 2008-12-11 | Syngenta Participations Ag | Process for starch liquefaction and fermentation |
| US7915020B2 (en) * | 2007-06-01 | 2011-03-29 | Syngenta Participations Ag | Process for starch liquefaction and fermentation |
| US7727726B2 (en) * | 2007-06-01 | 2010-06-01 | Syngenta Participations Ag | Process for starch liquefaction and fermentation |
| WO2009088465A2 (en) | 2008-01-02 | 2009-07-16 | Danisco Us Inc., Genencor Division | A process of obtaining ethanol without glucoamylase using pseudomonas saccharophila g4-amylase and variants thereof |
| US9816119B2 (en) | 2008-02-29 | 2017-11-14 | Syngenta Participations Ag | Methods for starch hydrolysis |
| MX2010013108A (es) | 2008-06-06 | 2010-12-21 | Danisco Inc | Produccion de glucosa a partir de almidon usando alfa-amilasas de bacillus subtilis. |
| MX2010013122A (es) | 2008-06-06 | 2011-01-21 | Danisco Inc | Composicion de enzima de sacarificacion y metodo de sacarificacion de la misma. |
| DK2297313T3 (en) * | 2008-06-06 | 2015-06-08 | Danisco Us Inc | ALPHA AMYLASE VARIETIES OF BACILLUS SUBTILIS AND METHODS OF USING IT |
| US7666457B1 (en) | 2008-08-19 | 2010-02-23 | Delavau Llc | Dry mixes comprising glycerine |
| EP2406373B1 (en) * | 2009-03-10 | 2014-05-28 | Danisco US Inc. | Bacillus megaterium strain dsm90-related alpha-amylases, and methods of use, thereof |
| RU2011144134A (ru) * | 2009-04-01 | 2013-05-10 | ДАНИСКО ЮЭс ИНК. | Композиции и способы, включающие варианты альфа-амилазы с измененными свойствами |
| ES2604666T3 (es) * | 2009-05-19 | 2017-03-08 | Dupont Nutrition Biosciences Aps | Polipéptidos de amilasa |
| CN102647918B (zh) * | 2009-08-07 | 2015-05-27 | 丹尼斯科美国公司 | 用于淀粉加工的α-淀粉酶混合物及其使用方法 |
| MX356389B (es) * | 2009-10-23 | 2018-05-28 | Danisco Us Inc | Metodos para reducir sacaridos azules. |
| WO2011072117A1 (en) | 2009-12-09 | 2011-06-16 | The Procter & Gamble Company | Fabric and home care products |
| WO2011091260A2 (en) * | 2010-01-25 | 2011-07-28 | Syngenta Participations Ag | Compositions and methods relating to dual activity enzymes having xylanase and cellulase activity |
| KR20140041801A (ko) | 2011-06-30 | 2014-04-04 | 노보자임스 에이/에스 | 알파-아밀라제 스크리닝 방법 |
| US9672126B2 (en) | 2011-12-15 | 2017-06-06 | Sybase, Inc. | Hybrid data replication |
| US20130159253A1 (en) * | 2011-12-15 | 2013-06-20 | Sybase, Inc. | Directing a data replication environment through policy declaration |
| GB2499463B (en) * | 2012-01-31 | 2014-04-02 | Verenium Corp | Reduced sugar syrups and methods of making reduced sugar syrups |
| HUE057894T2 (hu) | 2012-06-08 | 2022-06-28 | Danisco Us Inc | Alfa-amiláz változatok javított aktivitással keményítõpolimereken |
| BR112015023620B1 (pt) | 2013-03-15 | 2021-06-22 | Grain Processing Corporation | Preparação de malto-oligossacarídeos |
| US20160186102A1 (en) * | 2013-10-03 | 2016-06-30 | Danisco Us Inc. | Alpha-amylases from exiguobacterium, and methods of use, thereof |
| BR112017021639A2 (pt) | 2015-04-10 | 2018-07-24 | Syngenta Participations Ag | composições de ração animal e métodos de uso |
| CN108138447A (zh) * | 2015-08-14 | 2018-06-08 | 巴斯夫欧洲公司 | 用于纸和纸板的含水表面处理组合物 |
| FR3045055B1 (fr) | 2015-12-10 | 2020-02-21 | Roquette Freres | Hydrolysat d'amidon de basse viscosite presentant un comportement a la retrogradation ameliore |
| CN108431219A (zh) * | 2015-12-18 | 2018-08-21 | 巴斯夫酶有限责任公司 | α-淀粉酶的液体制剂 |
| DE102016208466A1 (de) | 2016-05-18 | 2017-11-23 | Henkel Ag & Co. Kgaa | Verbesserte Waschleistung durch eine neue alpha-Amylase aus Rhizoctonia solani |
| DE102016209880A1 (de) | 2016-06-06 | 2017-12-07 | Henkel Ag & Co. Kgaa | Neue Amylasen |
| WO2017220787A1 (en) * | 2016-06-24 | 2017-12-28 | Evaxion Biotech Aps | Vaccines against aearomonas salmonicida infection |
| CN106011107B (zh) * | 2016-06-30 | 2019-09-10 | 安徽工程大学 | 一种耐碱性α-淀粉酶及其基因工程菌的构建方法和应用 |
| BR112019004915A2 (pt) | 2016-09-16 | 2019-06-25 | Basf Se | método de modificação de pasta de fabricação de papel, pasta de fibra modificada com enzima, pasta de fibra de madeira macia modificada com enzima, e, produto de pasta ou folha contínua de papel. |
| DE102016221851A1 (de) | 2016-11-08 | 2018-05-09 | Henkel Ag & Co. Kgaa | Amylase für Wasch- und Reinigungsmittelanwendungen |
| CA3067218A1 (en) * | 2017-06-16 | 2018-12-20 | Basf Enzymes Llc | Method for increasing oil yield during ethanol production |
| WO2019075028A1 (en) | 2017-10-12 | 2019-04-18 | Syngenta Participations Ag | ENHANCED ANIMAL FEEDING COMPOSITIONS AND METHODS OF USE |
| MX2020004318A (es) | 2017-10-25 | 2020-08-13 | Basf Se | Enzimas beta-amilasa. |
| DE102017220757A1 (de) | 2017-11-21 | 2019-05-23 | Henkel Ag & Co. Kgaa | Amylase und eine solche enthaltendes Wasch- oder Reinigungsmittel |
| CA3093776A1 (en) * | 2018-03-13 | 2019-09-19 | Lallemand Hungary Liquidity Management Llc | Yeast expressing thermostable alpha-amylases for hydrolysis of starch |
| US20230091532A1 (en) * | 2018-03-13 | 2023-03-23 | Lallemand Hungary Liquidity Management Llc | Inactivated yeast and yeast product for improving fermentation yield |
| BR112020021692A2 (pt) | 2018-04-26 | 2021-01-26 | Basf Se | polipeptídeo tendo atividade de lipase, polipeptídeo híbrido, composição, polinucleotídeo variante, método para fabricar a variante de polipeptídeo, e, uso do polipeptídeo |
| WO2019211143A1 (en) | 2018-05-03 | 2019-11-07 | Basf Se | Amylase enzymes |
| US11530427B2 (en) * | 2018-05-25 | 2022-12-20 | Basf Se | Uses of surfactants in starch processing |
| DE102018208446A1 (de) | 2018-05-29 | 2019-12-05 | Henkel Ag & Co. Kgaa | Verbesserte Waschleistung durch eine neue alpha-Amylase aus Fomes fomentarius (Ffo) |
| DE102018208444A1 (de) | 2018-05-29 | 2019-12-05 | Henkel Ag & Co. Kgaa | Verbesserte Waschleistung durch eine neue alpha-Amylase aus Trametes hirsuta (Thi) |
| DE102018208445A1 (de) | 2018-05-29 | 2019-12-05 | Henkel Ag & Co. Kgaa | Verbesserte Waschleistung durch eine neue alpha-Amylase aus Fomitopsis pinicola (Fpi) |
| DE102018208443A1 (de) | 2018-05-29 | 2019-12-05 | Henkel Ag & Co. Kgaa | Verbesserte Waschleistung durch eine neue alpha-Amylase Irpex lacteus (IIa) |
| US12351841B2 (en) | 2018-05-29 | 2025-07-08 | Basf Se | Amylase enzymes |
| WO2020169563A1 (en) | 2019-02-20 | 2020-08-27 | Basf Se | Industrial fermentation process for bacillus using defined medium and magnesium feed |
| CN114127256A (zh) | 2019-02-20 | 2022-03-01 | 巴斯夫欧洲公司 | 用确定成分培养基和微量元素补料的芽孢杆菌工业发酵工艺 |
| WO2020185737A1 (en) | 2019-03-11 | 2020-09-17 | Basf Se | Amylases and methods for making and using them |
| US20220162576A1 (en) | 2019-03-25 | 2022-05-26 | Basf Se | Amylase enzymes |
| WO2020193532A1 (en) | 2019-03-25 | 2020-10-01 | Basf Se | Cleaning composition having amylase enzymes |
| US20220170001A1 (en) | 2019-03-25 | 2022-06-02 | Basf Se | Amylase Enzymes |
| CN114096271B (zh) | 2019-04-23 | 2024-04-12 | 巴斯夫欧洲公司 | β-淀粉酶变体 |
| WO2020231400A1 (en) | 2019-05-13 | 2020-11-19 | Halliburton Engergy Services, Inc. | Injectivity and production improvement in oil and gas fields |
| BR112021024243A2 (pt) * | 2019-06-05 | 2022-04-12 | Danisco Us Inc | Métodos para melhorar o teor de aminoácido de produtos de alimentação animal |
| FI3983425T3 (fi) | 2019-06-13 | 2025-11-19 | Basf Se | Menetelmä proteiinin talteen ottamiseksi käymisliemestä käyttämällä divalenttista kationia |
| US20230212506A1 (en) | 2019-07-05 | 2023-07-06 | Basf Se | Industrial fermentation process for microbial cells using a fed-batch pre-culture |
| CN114364795A (zh) | 2019-08-22 | 2022-04-15 | 巴斯夫欧洲公司 | 淀粉酶变体 |
| AU2023272468A1 (en) | 2022-05-14 | 2024-11-14 | Novonesis Plant Biosolutions A/S | Compositions and methods for preventing, treating, supressing and/or eliminating phytopathogenic infestations and infections |
| CN119060988B (zh) * | 2024-09-30 | 2025-08-22 | 南京大学 | 一种耐盐的α-淀粉酶突变体及其应用 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH09173077A (ja) * | 1995-07-20 | 1997-07-08 | Tadayuki Imanaka | 超耐熱性酸性α−アミラーゼおよび該α−アミラーゼ産生遺伝子を含むＤＮＡ断片 |
| WO1997044361A1 (en) * | 1996-05-22 | 1997-11-27 | Recombinant Biocatalysis, Inc. | Endoglucanases |
Family Cites Families (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3847740A (en) * | 1972-10-02 | 1974-11-12 | Cpc International Inc | Process for the production of levulose-bearing syrups |
| JPS5823799A (ja) | 1981-08-03 | 1983-02-12 | 株式会社林原生物化学研究所 | 高純度マルト−スの製造方法 |
| JPS5872598A (ja) * | 1981-10-26 | 1983-04-30 | Hayashibara Biochem Lab Inc | 高純度イソマルト−スの製造方法 |
| US4557927A (en) * | 1983-03-10 | 1985-12-10 | Kabushiki Kaisha Hoyashibara | Food products and process for producing same |
| DE3688920T4 (de) | 1985-07-03 | 1995-08-31 | Genencor Int | Hybride Polypeptide und Verfahren zu deren Herstellung. |
| JPS62104580A (ja) | 1985-10-30 | 1987-05-15 | Kunio Yamane | 高耐熱性酵素発現ｄｎａ |
| CA1272150A (en) * | 1985-12-03 | 1990-07-31 | Paul Ducroo | Production of glucose syrups and purified starches from wheat and other cereal starches containing pentosans |
| GB8609288D0 (en) * | 1986-04-16 | 1986-05-21 | Ici Plc | Debranching enzyme |
| DK311186D0 (da) | 1986-06-30 | 1986-06-30 | Novo Industri As | Enzymer |
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| JP2696537B2 (ja) | 1988-10-28 | 1998-01-14 | 東和化成工業株式会社 | 高純度マルトースの製造方法 |
| AU7791991A (en) | 1990-04-24 | 1991-11-11 | Stratagene | Methods for phenotype creation from multiple gene populations |
| US6582908B2 (en) * | 1990-12-06 | 2003-06-24 | Affymetrix, Inc. | Oligonucleotides |
| WO1993000426A1 (en) | 1991-06-25 | 1993-01-07 | Novo Nordisk A/S | Mammalian pancreatic lipase and variant thereof |
| DE69332781T2 (de) | 1992-12-28 | 2004-02-12 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Reinigung von Trehalose |
| KR100322793B1 (ko) | 1993-02-11 | 2002-06-20 | 마가렛 에이.혼 | 산화안정성알파-아밀라아제 |
| JP3559585B2 (ja) | 1993-06-03 | 2004-09-02 | 株式会社林原生物化学研究所 | トレハロース遊離酵素とその製造方法並びに用途 |
| EP0648843A1 (en) * | 1993-10-01 | 1995-04-19 | Takara Shuzo Co. Ltd. | DNA encoding a hyperthermostable alpha-amylase |
| JPH07143880A (ja) * | 1993-10-01 | 1995-06-06 | Takara Shuzo Co Ltd | 超耐熱性α−アミラーゼ遺伝子 |
| BR9407767A (pt) * | 1993-10-08 | 1997-03-18 | Novo Nordisk As | Variante de enzima &-amilase uso da mesma construção de DNA vetor de express o recombinante célula processos para produzir uma &-amilase hibrida e para preparar uma variante de uma &-amilase aditivo detergente e composições detergentes |
| DK0828753T3 (da) | 1995-06-02 | 2003-06-30 | Novozymes As | A1/Fe-behandling af en proteinopløsning efterfulgt af membranopkoncentrering |
| US5736499A (en) | 1995-06-06 | 1998-04-07 | Genencor International, Inc. | Mutant A-amylase |
| US5965408A (en) | 1996-07-09 | 1999-10-12 | Diversa Corporation | Method of DNA reassembly by interrupting synthesis |
| US5939250A (en) | 1995-12-07 | 1999-08-17 | Diversa Corporation | Production of enzymes having desired activities by mutagenesis |
| US6479258B1 (en) * | 1995-12-07 | 2002-11-12 | Diversa Corporation | Non-stochastic generation of genetic vaccines |
| CN1222938A (zh) * | 1996-05-14 | 1999-07-14 | 金克克国际有限公司 | 经修饰具有改变了的钙离子吉合性质的α－淀粉酶 |
| WO1998016633A1 (en) * | 1996-10-11 | 1998-04-23 | Novo Nordisk A/S | Alpha-amylase fused to cellulose binding domain, for starch degradation |
| WO1998045417A1 (en) * | 1997-04-09 | 1998-10-15 | Michigan State University | HYPERTHERMOSTABLE α-AMYLASE |
| EP2386568B1 (en) * | 1997-10-30 | 2014-08-06 | Novozymes A/S | Alpha-amylase mutants |
| AUPP209298A0 (en) * | 1998-03-02 | 1998-03-26 | Uniphase Fibre Components Pty Limited | Grating writing techniques |
| FR2778412B1 (fr) | 1998-05-05 | 2002-08-09 | Univ Reims Champagne Ardennes | Procede pour preparer une enzyme alpha-amylase thermophile et enzyme ainsi obtenue |
| AU750509B2 (en) | 1998-06-24 | 2002-07-18 | Sanofi-Aventis Deutschland Gmbh | Mumbaistatin, a process for its production and its use as a pharmaceutical |
| US6284956B1 (en) | 1998-06-25 | 2001-09-04 | Applied Phytologics, Inc. | Plant selectable marker and plant transformation method |
| CA2363551A1 (en) | 1999-03-25 | 2000-10-05 | Genset S.A. | Biallelic markers related to genes involved in drug metabolism |
| JP4668426B2 (ja) * | 1999-03-30 | 2011-04-13 | ノボザイムス アクティーゼルスカブ | α−アミラーゼ変異体 |
| US7192746B2 (en) * | 2000-05-22 | 2007-03-20 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | α-Isomaltosyltransferase, process for producing the same and use thereof |
| WO2002029079A2 (en) | 2000-10-04 | 2002-04-11 | Maxygen, Inc. | Enantioselective production of amino carboxylic acids |
| CA2833423C (en) * | 2001-02-21 | 2019-03-19 | Verenium Corporation | Enzymes having alpha amylase activity and methods of use thereof |
| US7659102B2 (en) * | 2001-02-21 | 2010-02-09 | Verenium Corporation | Amylases, nucleic acids encoding them and methods for making and using them |
| US7560126B2 (en) * | 2001-02-21 | 2009-07-14 | Verenium Corporation | Amylases, nucleic acids encoding them and methods for making and using them |
| DE10131441A1 (de) | 2001-06-29 | 2003-01-30 | Henkel Kgaa | Eine neue Gruppe von alpha-Amylasen sowie ein Verfahren zur Identifizierung und Gewinnung neuer alpha-Amylasen |
| AU2002319764A1 (en) | 2001-08-03 | 2003-02-17 | Elitra Pharmaceuticals, Inc. | Nucleic acids of aspergillus fumigatus encoding industrial enzymes and methods of use |
| EP1432798B1 (en) * | 2001-08-27 | 2010-11-17 | Syngenta Participations AG | Self-processing plants and plant parts |
| US20040025925A1 (en) * | 2002-08-06 | 2004-02-12 | Jeremy Gin | Adjustable mobility-aid apparatus that avoids triggering alarms |
| BRPI0408158A8 (pt) | 2003-03-06 | 2017-12-05 | Diversa Corp | Amilases, ácidos nucléicos codificando-as e métodos para preparar e empregá-las |
| MX2011006166A (es) | 2008-12-15 | 2011-10-10 | Danisco Inc | Alfa-amilasas hibridas. |
| WO2012155131A1 (en) | 2011-05-12 | 2012-11-15 | Sealy Technology, Llc | Advanced conformance encased coil spring units |
| AU2014284148B2 (en) | 2013-06-21 | 2017-02-23 | Bio-Rad Laboratories, Inc. | Microfluidic system with fluid pickups |
-
2002
- 2002-02-21 CA CA2833423A patent/CA2833423C/en not_active Expired - Lifetime
- 2002-02-21 CA CA3032990A patent/CA3032990C/en not_active Expired - Lifetime
- 2002-02-21 BR BRPI0207770A patent/BRPI0207770A8/pt not_active IP Right Cessation
- 2002-02-21 EP EP10184381.1A patent/EP2333097B1/en not_active Expired - Lifetime
- 2002-02-21 DK DK10184478.5T patent/DK2333099T3/da active
- 2002-02-21 AT AT02706401T patent/ATE510023T1/de active
- 2002-02-21 CN CN201410559804.5A patent/CN104593394A/zh active Pending
- 2002-02-21 EP EP02723192.7A patent/EP1392815B1/en not_active Expired - Lifetime
- 2002-02-21 CA CA2438884A patent/CA2438884C/en not_active Expired - Lifetime
- 2002-02-21 CN CN02808640A patent/CN100577809C/zh not_active Expired - Lifetime
- 2002-02-21 WO PCT/US2002/005068 patent/WO2002068589A2/en not_active Ceased
- 2002-02-21 EP EP02706401A patent/EP1370674B1/en not_active Expired - Lifetime
- 2002-02-21 DK DK09171688.6T patent/DK2169076T3/en active
- 2002-02-21 DK DK10184381.1T patent/DK2333097T3/da active
- 2002-02-21 CA CA3081363A patent/CA3081363A1/en not_active Abandoned
- 2002-02-21 CA CA2897239A patent/CA2897239A1/en not_active Abandoned
- 2002-02-21 EP EP10184415.7A patent/EP2333098B1/en not_active Expired - Lifetime
- 2002-02-21 US US10/081,739 patent/US7273740B2/en not_active Expired - Lifetime
- 2002-02-21 AU AU2002240489A patent/AU2002240489C1/en not_active Ceased
- 2002-02-21 PT PT02706401T patent/PT1370674E/pt unknown
- 2002-02-21 MX MXPA03007527A patent/MXPA03007527A/es active IP Right Grant
- 2002-02-21 EP EP10184478.5A patent/EP2333099B1/en not_active Expired - Lifetime
- 2002-02-21 ES ES09171688.6T patent/ES2613277T3/es not_active Expired - Lifetime
- 2002-02-21 WO PCT/US2002/005538 patent/WO2002068597A2/en not_active Ceased
- 2002-02-21 CN CN200910224585.4A patent/CN101724640B/zh not_active Expired - Fee Related
- 2002-02-21 ES ES10184478.5T patent/ES2650636T3/es not_active Expired - Lifetime
- 2002-02-21 DK DK02706401.3T patent/DK1370674T3/da active
- 2002-02-21 EP EP10182375A patent/EP2292784A3/en not_active Withdrawn
- 2002-02-21 US US10/081,872 patent/US7407677B2/en not_active Expired - Lifetime
- 2002-02-21 CA CA2438205A patent/CA2438205C/en not_active Expired - Lifetime
- 2002-02-21 ES ES10184381.1T patent/ES2637501T3/es not_active Expired - Lifetime
- 2002-02-21 JP JP2002568685A patent/JP2004533219A/ja active Pending
- 2002-02-21 EP EP09171688.6A patent/EP2169076B1/en not_active Expired - Lifetime
- 2002-02-21 EP EP17198525.2A patent/EP3305894A1/en not_active Withdrawn
- 2002-02-21 ES ES10184415.7T patent/ES2604329T3/es not_active Expired - Lifetime
- 2002-02-21 JP JP2002568693A patent/JP2004533220A/ja not_active Withdrawn
-
2003
- 2003-08-20 ZA ZA2003/06486A patent/ZA200306486B/en unknown
-
2006
- 2006-04-06 US US11/400,030 patent/US7666633B2/en not_active Expired - Lifetime
- 2006-09-04 AU AU2006207843A patent/AU2006207843C1/en not_active Ceased
-
2007
- 2007-01-09 US US11/621,543 patent/US7816108B2/en not_active Expired - Lifetime
- 2007-01-09 US US11/621,528 patent/US7785855B2/en not_active Expired - Lifetime
- 2007-01-09 US US11/621,534 patent/US7781201B2/en not_active Expired - Lifetime
- 2007-11-27 JP JP2007305644A patent/JP4690381B2/ja not_active Expired - Fee Related
-
2008
- 2008-05-26 JP JP2008136876A patent/JP4846760B2/ja not_active Expired - Fee Related
-
2009
- 2009-09-25 AU AU2009222426A patent/AU2009222426B2/en not_active Ceased
- 2009-09-25 US US12/567,550 patent/US8334118B2/en not_active Expired - Fee Related
-
2010
- 2010-06-10 JP JP2010132602A patent/JP5576718B2/ja not_active Expired - Fee Related
- 2010-11-30 ZA ZA2010/08280A patent/ZA201008280B/en unknown
-
2011
- 2011-02-04 JP JP2011022288A patent/JP5719621B2/ja not_active Expired - Lifetime
- 2011-08-18 CY CY20111100795T patent/CY1111771T1/el unknown
-
2012
- 2012-11-06 US US13/669,707 patent/US20130224800A1/en not_active Abandoned
-
2014
- 2014-08-05 JP JP2014159425A patent/JP6305866B2/ja not_active Expired - Fee Related
-
2016
- 2016-04-22 US US15/135,732 patent/US10047350B2/en not_active Expired - Fee Related
-
2017
- 2017-01-04 JP JP2017000091A patent/JP6402205B2/ja not_active Expired - Fee Related
-
2018
- 2018-07-23 JP JP2018137584A patent/JP2019010100A/ja active Pending
- 2018-08-02 US US16/052,853 patent/US20180334660A1/en not_active Abandoned
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH09173077A (ja) * | 1995-07-20 | 1997-07-08 | Tadayuki Imanaka | 超耐熱性酸性α−アミラーゼおよび該α−アミラーゼ産生遺伝子を含むＤＮＡ断片 |
| WO1997044361A1 (en) * | 1996-05-22 | 1997-11-27 | Recombinant Biocatalysis, Inc. | Endoglucanases |
Non-Patent Citations (6)
| Title |
|---|
| GenBank Accession No. AF017454 (nucleic acid sequence) and AAB87860 (protein sequence), Jones, * |
| GenBank Accession No. E13334 (gene sequence) & JP 09173077 A (Imanaka, T. et al.) 8 July 1997 * |
| GenBank Accession Nos. AF068255 (nucleic acid sequence) and AAC97877 (protein sequence), * |
| GenBank Accession Nos. D83793 (nucleic acid seq.) and BAA21130 (protein seq.), Tachibana, Y. et al (1996) J. Ferment. Bioeng. 82: 224-232 * |
| Leveque, E et al. (2000) FEMS Microbiol. Lett. 186(1): 67-71 * |
| R. A. et al. J. Appl. Microbiol. (1999) 86(1): 93-107. * |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002240489C1 (en) | Enzymes having alpha amylase activity and methods of use thereof | |
| US7323336B2 (en) | Enzymes having alpha amylase activity and methods of use thereof | |
| AU2002240489A1 (en) | Enzymes having alpha amylase activity and methods of use thereof | |
| AU2006201514B2 (en) | Enzymes having alpha amylase activity and methods of use thereof | |
| AU2015221461B2 (en) | Enzymes having alpha amylase activity and methods of use thereof | |
| AU2012238328B2 (en) | Enzymes having alpha amylase activity and methods of use thereof | |
| HK1060373B (en) | Enzymes having alpha amylase activity and methods of use thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| TC | Change of applicant's name (sec. 104) |
Owner name: VERENIUM CORPORATION Free format text: FORMER NAME: DIVERSA CORPORATION |
|
| DA2 | Applications for amendment section 104 |
Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 07 AUG 2008. |
|
| DA3 | Amendments made section 104 |
Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 07 AUG 2008 |
|
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |